Skip to search formSkip to main contentSkip to account menu

Risperidone 4 MG Disintegrating Oral Tablet [Risperdal]

Known as: RisperDAL 4 MG Disintegrating Oral Tablet, Risperdal M-Tab 4 MG Disintegrating Oral Tablet, risperidone 4 mg ORAL TABLET, ORALLY DISINTEGRATING [RISPERDAL M-TAB] 
National Institutes of Health

Related topics

Related topics

12 relations
AspartameDisintegrating Oral TabletGelatinGlycine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Psychotropic Medications as Treatments for People with Autism Spectrum Disorder
Two drugs, risperidone (Risperdal®) and aripiprazole (Abilify®), are approved by the Food and Drug Administration for treating… 
2008
2008
DADS/DSHS EXECUTIVE FORMULARY COMMITTEE MINUTES
Adverse Drug Reaction Reports The Executive Formulary Committee received two adverse drug reaction reports. In the first case, a… 
2006
2006
LONG-ACTING INJECTION Increased Mortality in Elderly Patients with Dementia –Related Psychosis Elderly patients with dementia-related psychosis treated with atypical antipsychotic drugs are at an…
Increased Mortality in Elderly Patients with Dementia –Related Psychosis Elderly patients with dementia-related psychosis treated… 
2003
2003
Aripiprazole: A New Antipsychotic Agent with a Unique Mechanism
Although early antipsychotic agents, such as chlorpromazine (Thorazine®, GlaxoSmithKline) and haloperidol (Haldol®, OrthoMcNeill… 
Review
1995
Review
1995
Risperidone in the treatment of psychosis; a concise review
Summary Risperidone (Risperdal®) is a recently developed antipsychotic drug with the combination of serotonin-5HT2A-and dopamine… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)